100 related articles for article (PubMed ID: 3206329)
1. [Visualizing muscular phosphorus metabolites in peripheral arterial occlusive disease].
Rexroth W; Semmler W; Gückel F; Stadtlander M; von Kaick G; Hild R
Vasa Suppl; 1988; 23():115-20. PubMed ID: 3206329
[No Abstract] [Full Text] [Related]
2. [In vivo 31-phosphorus MR spectroscopy of the calf musculature in arterial occlusive diseases].
Melchert UH; Brinkmann G; Förger K; Gleim M; Wunsch-Binder F; Maier C; Zick G
Rofo; 1992 Apr; 156(4):346-52. PubMed ID: 1571516
[TBL] [Abstract][Full Text] [Related]
3. [Phosphorus-31 NMR spectrometry of the calf muscles in patients with arterial claudication. Preliminary results].
Le Bas JF; Reutenauer H; Franco A; Magne JL; Benabid AL
J Mal Vasc; 1987; 12(1):70-7. PubMed ID: 3559414
[TBL] [Abstract][Full Text] [Related]
4. [Muscular energetics studied by nuclear magnetic resonance spectroscopy of phosphorus (cardiac and skeletal muscles)].
Rossi A
Arch Int Physiol Biochim; 1988 Sep; 96(4):A393-409. PubMed ID: 2463818
[No Abstract] [Full Text] [Related]
5. Muscle metabolism during exercise in patients with occlusive arterial disease: effect of reconstructive surgery.
Pernow B; Saltin B; Wahren J; Cronestrand R
Scand J Clin Lab Invest Suppl; 1973; 128():21-5. PubMed ID: 4764586
[No Abstract] [Full Text] [Related]
6. Effects of inspiratory loading on 31phosphorus magnetic resonance spectroscopy of the inspiratory intercostal muscles in normal humans.
Lopata M; Onal E; Aronson RM; Carley DW
Trans Assoc Am Physicians; 1988; 101():203-11. PubMed ID: 3269679
[No Abstract] [Full Text] [Related]
7. [Effects of a nucleotide-nucleoside mixture on ischemic muscle metabolism in patients with stage II peripheral arterial occlusive disease. MR spectroscopic and biochemical analytic results].
Rexroth W; Huber KH; Rädle J; Semmler W; van Kaick G
Vasa; 1994; 23(2):98-108. PubMed ID: 8036845
[TBL] [Abstract][Full Text] [Related]
8. MRI and MRS of the skeletal muscle.
Träber F; Kaiser WA; Reiser MF; Nägele M
Bildgebung; 1992 Sep; 59(3):156-8. PubMed ID: 1422001
[TBL] [Abstract][Full Text] [Related]
9. Muscle metabolism in patients with peripheral vascular disease investigated by 31P nuclear magnetic resonance spectroscopy.
Hands LJ; Bore PJ; Galloway G; Morris PJ; Radda GK
Clin Sci (Lond); 1986 Sep; 71(3):283-90. PubMed ID: 3757432
[TBL] [Abstract][Full Text] [Related]
10. [Metabolic studies of muscles and blood in ergometrically stressed patients with arterial occlusive disease].
Nissen P; Alexander K; Maass U
Verh Dtsch Ges Kreislaufforsch; 1977; 43():176. PubMed ID: 613562
[No Abstract] [Full Text] [Related]
11. Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy.
Arnold DL; Taylor DJ; Radda GK
Ann Neurol; 1985 Aug; 18(2):189-96. PubMed ID: 4037759
[TBL] [Abstract][Full Text] [Related]
12. P31-NMR studies of muscle in patients with venous insufficiency.
Taheri SA; Pollack L; Loomis R
Int Angiol; 1987; 6(1):95-8. PubMed ID: 3624954
[TBL] [Abstract][Full Text] [Related]
13. [The value of 31 P nuclear magnetic resonance spectroscopy in follow up of Fontaine stage IIb peripheral arterial occlusive disease].
Scheffler P; Leipnitz G; Gross J; Kuhn W; Windeck P
Vasa Suppl; 1991; 33():318-9. PubMed ID: 1788734
[TBL] [Abstract][Full Text] [Related]
14. In vivo P-NMR spectroscopy: muscle energy exchange in paramyotonia patients.
Lehmann-Horn F; Höpfel D; Rüdel R; Ricker K; Küther G
Muscle Nerve; 1985 Sep; 8(7):606-10. PubMed ID: 4047092
[TBL] [Abstract][Full Text] [Related]
15. [Topical nuclear magnetic resonance--a non-invasive probe for biochemical measurements in living organisms].
Aue WP
Radiologe; 1983 Aug; 23(8):357-60. PubMed ID: 6578539
[TBL] [Abstract][Full Text] [Related]
16. Phosphorus magnetic resonance spectroscopy: a noninvasive technique for the study of occlusive arterial leg disease and peripheral vasodilator therapy.
Wahl DG; Simon JP; Robin B; Walker P; Jouanny P; Escanye JM; Paille F; Schmidt C; Brunotte F; Robert J
Angiology; 1994 May; 45(5):367-76. PubMed ID: 8172384
[TBL] [Abstract][Full Text] [Related]
17. Prerequisites and initial experience for the noninvasive routine evaluation of viability of experimental and human organ transplants by magnetic resonance spectroscopy.
Henze E; Lietzenmayer R; Kunz R; Schnur G; Clausen M; Schoser K; Beger HG; Adam WE; Ankele J; Beck C
Transplant Proc; 1990 Oct; 22(5):2404-8. PubMed ID: 2219413
[No Abstract] [Full Text] [Related]
18. Brain death-induced alterations in myocardial workload and high-energy phosphates: a phosphorus 31 magnetic resonance spectroscopy study in the cat.
Brandon Bravo Bruinsma GJ; Nederhoff MG; te Boekhorst BC; Bredée JJ; Ruigrok TJ; van Echteld CJ
J Heart Lung Transplant; 1998 Oct; 17(10):984-90. PubMed ID: 9811406
[TBL] [Abstract][Full Text] [Related]
19. Assessment of muscular metabolism in peripheral arterial occlusive disease using 31P nuclear magnetic resonance spectroscopy. Comparison with metabolite concentrations in femoral blood.
Rexroth W; Semmler W; Gückel F; Stadtlander M; Weicker H; Hild R; van Kaick G
Klin Wochenschr; 1989 Aug; 67(16):804-12. PubMed ID: 2796250
[TBL] [Abstract][Full Text] [Related]
20. [Modification of ischemia and reperfusion damage of skeletal muscles with allopurinol: in vivo 31P MR spectroscopy of the posterior limb of the rat].
Gürke L; Marx A; Erhard P; Sutter PM; Landmann J; Heberer M
Helv Chir Acta; 1993 Jun; 59(5-6):877-80. PubMed ID: 8376157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
